1887

Abstract

Qatar has tremendous efforts and expanded funds in establishing highly-informative genomic resources. Qatar Biobank for Medical Research and Qatar Genome Programme are examples of such efforts. There are certain challenges as well as opportunities in the utilization of these resources for feeding the nationally funded research. This includes determining which actionable plans that require implementation to maximize the benefits and output of these genomic resources. The employment of genomic and large data programs in translational research and national clinical trials is the ultimate goal we aim to accomplish. Taking into consideration the trials readiness and outcome measures, the panel’s discussion will address the best first examples to bring precision medicine to practice in Qatar. The development of clinical, genomic, and proteomic sets of databases for Qatar based NMDs-patients should serve the Qatar National Plans in the field of genetics of rare monogenic diseases.

Loading

Article metrics loading...

/content/papers/10.5339/qproc.2020.NMD.24
2020-09-15
2020-09-23
Loading full text...

Full text loading...

http://instance.metastore.ingenta.com/content/papers/10.5339/qproc.2020.NMD.24
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error